Reduced Dose and Intermittent Treatment with Lapatinib and Trastuzumab for Potent Blockade of the HER Pathway in HER2/neu-Overexpressing Breast Tumor Xenografts (Q34694605)
scientific article published on December 7, 2010
Language:
(P31) (Q13442814)
(P50) (Q39194525)
(Q90949247)
(Q86340923)
(P304) 1351-1361
(P407) (Q1860)
(P433) 6
(P478) 17
(P577) Tuesday, December 7, 2010
(P921) (Q61643320)
(Q64148587)
(Q412616)
(Q23929670)
(Q112042499)
(P953) https://aacrjournals.org/clincancerres/article-pdf/17/6/1351/2002883/1351.pdf
http://clincancerres.aacrjournals.org/cgi/content/abstract/17/6/1351
https://europepmc.org/articles/PMC3060302
https://europepmc.org/articles/PMC3060302?pdf=render
https://doi.org/10.1158/1078-0432.ccr-10-1905
https://aacrjournals.org/clincancerres/article-pdf/17/6/1351/2002883/1351.pdf
(P1433) (Q332253)
(P1476) "Reduced dose and intermittent treatment with lapatinib and trastuzumab for potent blockade of the HER pathway in HER2/neu-overexpressing breast tumor xenografts" (language: en)
"Reduced Dose and Intermittent Treatment with Lapatinib and Trastuzumab for Potent Blockade of the HER Pathway in HER2/neu-Overexpressing Breast Tumor Xenografts" (language: en)
(P2093) Yen-Chao Wang
Catherine Huang
Ilenia Migliaccio
Meng-Fen Wu
Carolina Gutierrez
Robin Ward
Robert Soliz
Mothaffar F. Rimawi
Lisa S. Wiechmann
Susan G. Hilsenbeck
C. Kent Osborne
(P2860) (Q24641848)
(Q34530485)
(Q39874714)
(Q39908130)
(Q29617584)
(Q34508475)
(Q40093663)
(Q40138970)
(Q40169783)
(Q40174208)
(Q40243239)
(Q29619032)
(Q40321992)
(Q29616112)
(Q27824847)
(Q31148247)
(Q34394358)
(Q40544950)
(Q28131776)
(Q34532249)
(Q27860884)
(Q27824766)
(Q34135007)
(Q33845160)
(Q27860985)
(Q42807740)
(Q24309266)
(Q28287906)
(Q43250043)
(Q46796554)
(Q53366750)
(Q44245527)
(Q44127144)
(Q44120544)
(Q54031538)
(Q54172521)
(Q77124890)
(Q95816296)
other details
description scientific article published on December 7, 2010

External Links